+13.4%
AUR vs GSK
+31.2%
-17.8%
-38.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.3% | -1.9% | +2.2% | +0.1% |
| 7D | +8.7% | -1.8% | +10.6% | +8.5% |
| 30D | -5.2% | -2.2% | -3.1% | -5.3% |
| 3M | -7.3% | -1.8% | -5.5% | -7.3% |
| 6M | +41.2% | -10.6% | +51.8% | +40.6% |
| YTD | +65.1% | +4.4% | +60.7% | +66.8% |
| 1Y | +13.4% | +30.4% | -17.0% | +21.8% |
| All | +13.4% | +31.2% | -17.8% | +21.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling